Horizon Pharma plc
Feb 14, 2017

Horizon Pharma plc to Participate in Cowen and Company 37th Annual Health Care Conference

DUBLIN, Ireland, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will present at the Cowen and Company 37th Annual Health Care Conference at 2:40 p.m. ET on March 6, 2017 in Boston, MA.

The conference presentation will be webcast live and may be accessed by visiting Horizon's investor relations section of the website at http://ir.horizon-pharma.com.  A replay of the webcast will be available for the event.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  The Company markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:



Tina Ventura

Senior Vice President, Investor Relations

investor-relations@horizonpharma.com



U.S. Media:

Geoff Curtis

Senior Vice President, Corporate Communications

media@horizonpharma.com



Ireland Media:

Ray Gordon

Gordon MRM

ray@gordonmrm.ie

Source: Horizon Pharma plc

News Provided by Acquire Media